Q-linea is building a launch platform during 2023 - Redeye

Q-linea is in a transition period after the break with Thermo Fisher, and in Q1 there are no reported sales. Q-linea has decided on a cost-saving program and has a targeted regional sales strategy in Europe. Q-linea points to a UK order of the ASTar units from the UK partner Pro-Lab Diagnostics which is positive for the 2023 outlook.

Länk till analysen i sin helhet: https://www.redeye.se/research/904146/q-linea-q-linea-is-building-a-launch-platform-during-2023?utm_source=finwire&utm_medium=RSS